Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of M108101 in patients with acne vulgaris
jRCT2080221392Phase 2
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing M108101 with Placebo (2 arms).
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2080221392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221392.